Attention Bias Modification Treatment (ABMT) Clinical Trial
Official title:
Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)
Verified date | December 2014 |
Source | Tel Aviv University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Israel: Ministry of Health |
Study type | Interventional |
Patients with Post Traumatic Stress Disorder (PTSD) will be randomly assigned to either
Attention Bias Modification Treatment (ABMT) designed to normalize threat-related attention
biases or a placebo control condition not designed to change attention patterns. Outcome
measures will be Post Traumatic Stress Disorder (PTSD), depression, and anxiety symptoms as
measured by gold standard questionnaires and symptom counts derived from structured clinical
interviews.
We expect to see significant Post Traumatic Stress Disorder symptom reduction in the
Attention Bias Modification Treatment (ABMT) group relative to the placebo control group in
which no symptomatic relief is expected.
Status | Completed |
Enrollment | 52 |
Est. completion date | March 2013 |
Est. primary completion date | March 2013 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Combat-related PTSD diagnosis Exclusion Criteria: - Other treatment |
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Israel | Tel Aviv University | Tel Aviv |
Lead Sponsor | Collaborator |
---|---|
Tel Aviv University |
Israel,
Hakamata Y, Lissek S, Bar-Haim Y, Britton JC, Fox NA, Leibenluft E, Ernst M, Pine DS. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiatry. 2010 Dec 1;68(11):982-90. doi: 10.1016/j.biopsych.2010.07.021. Erratum in: Biol Psychiatry. 2012 Sep 1;72(5):429. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinician-Administered PTSD Scale (CAPS) | The clinician-Administered PTSD Scale (CAPS) is a 30-item structured interview that corresponds to the DSM-IV criteria for PTSD (Blake, Weathers, Nagy, Kaloupek, Charney, & Keane, 1995). | 40 minutes | No |
Secondary | PTSD Check List (PCL) | Post-traumatic Stress symptoms will be evaluated using the 17-item National Center for PTSD Checklist of the Department of Veterans Affairs- PCL (Blanchard, Jones-Alexander, Buckley, & Forneris, 1996; Hoge, 2004; Kang, Natelson, Mahan, Lee, & Murphy, 2003). | 10 minutes | No |